| P50 | author | Erin E Congdon | Q80934739 |
| P2093 | author name string | Jeff Kuret | |
| | Karen E Duff | |
| | Nicolette S Honson | |
| | Edward Chang | |
| P2860 | cites work | Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines | Q24598853 |
| | High resolution two-dimensional electrophoresis of proteins | Q24608190 |
| | Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum | Q24657634 |
| | Alzheimer's disease: paired helical filaments and cytomembranes | Q28301717 |
| | Progressive white matter pathology in the spinal cord of transgenic mice expressing mutant (P301L) human tau. | Q50476769 |
| | Inhibition of nitric oxide synthesis by methylene blue | Q50785727 |
| | Complexation of polymethine dyes with human serum albumin: a spectroscopic study. | Q51052169 |
| | Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties and spectroscopic in vivo characterization. | Q52969599 |
| | The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. | Q53215353 |
| | Organotypic slice cultures from transgenic mice as disease model systems. | Q53252643 |
| | Apoptosis induced by DNA primase inhibitor 3,3'-diethyl-9-methylthia-carbocyanine iodide in human leukemia HL-60 cells. | Q53581490 |
| | Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work | Q57897029 |
| | Pharmacokinetics of biliary excretion in man. VI. Indocyanine green | Q67953484 |
| | Inhibition of mitochondrial and Paracoccus denitrificans NADH-ubiquinone reductase by oxacarbocyanine dyes. A structure-activity study | Q70764193 |
| | Inhibition of cell division and growth by a redox series of cyanine dyes | Q71150055 |
| | Fluorescein and indocyanine green angiography in vascular chorioretinal diseases | Q77760991 |
| | The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function | Q78802805 |
| | Color and constitution: one hundred years of research | Q80917252 |
| | DNA-templated assembly of helical cyanine dye aggregates: a supramolecular chain polymerization | Q81183106 |
| | Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease | Q28910345 |
| | Tau-mediated neurodegeneration in Alzheimer's disease and related disorders | Q29618148 |
| | Nucleation-dependent tau filament formation: the importance of dimerization and an estimation of elementary rate constants | Q30481896 |
| | ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors | Q31028010 |
| | Cyanine dyes as protectors of K562 cells from photosensitized cell damage | Q31385901 |
| | Potency of a tau fibrillization inhibitor is influenced by its aggregation state | Q33287254 |
| | Differentiating Alzheimer disease-associated aggregates with small molecules | Q33296123 |
| | Inhibitory effects of two structurally related carbocyanine laser dyes on the activity of bovine heart mitochondrial and Paracoccus denitrificans NADH-ubiquinone reductase. Evidence for a rotenone-type mechanism | Q33383756 |
| | A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis | Q33720044 |
| | Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes | Q33838732 |
| | Differential incorporation of tau isoforms in Alzheimer's disease. | Q33900014 |
| | Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction | Q34104430 |
| | Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells | Q34264428 |
| | Cyanine dyes as intercalating agents: kinetic and thermodynamic studies on the DNA/Cyan40 and DNA/CCyan2 systems | Q34350480 |
| | Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways | Q34583654 |
| | Blue dyes, blue people: the systemic effects of blue dyes when administered via different routes | Q34637985 |
| | Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation | Q35748867 |
| | Potent inhibition of tau fibrillization with a multivalent ligand | Q36103300 |
| | Inhibition of DNA primase and induction of apoptosis by 3,3'-diethyl-9-methylthia-carbocyanine iodide in hepatocellular carcinoma BEL-7402 cells | Q36474287 |
| | Photosensitization by 3,3'-dihexyloxacarbocyanine iodide: specific disruption of microtubules and inactivation of organelle motility | Q36703115 |
| | Mitochondria and human cancer | Q36740525 |
| | Xenobiotic transporters: ascribing function from gene knockout and mutation studies | Q36910081 |
| | Pathogenic missense MAPT mutations differentially modulate tau aggregation propensity at nucleation and extension steps | Q37001433 |
| | Small-molecule mediated neuroprotection in an in situ model of tauopathy | Q37087223 |
| | Tau aggregation and toxicity in tauopathic neurodegenerative diseases | Q37238281 |
| | Is tau aggregation toxic or protective? | Q37238304 |
| | Mitotracker green is a P-glycoprotein substrate | Q40592480 |
| | Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant | Q40990869 |
| | Cytotoxic effect of thiacarbocyanine dyes on human colon carcinoma cells and inhibition of bovine heart mitochondrial NADH-ubiquinone reductase activity via a rotenone-type mechanism by two of the dyes | Q41573846 |
| | Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein | Q42491661 |
| | Multidrug resistance p-glycoprotein 2 is essential for the biliary excretion of indocyanine green | Q43575383 |
| | Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures. | Q44714742 |
| | Ligand-dependent inhibition and reversal of tau filament formation | Q44789587 |
| | Electron microscopy as a quantitative method for investigating tau fibrillization | Q44906884 |
| | Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human. | Q46474570 |
| | Cyanine dye N744 inhibits tau fibrillization by blocking filament extension: implications for the treatment of tauopathic neurodegenerative diseases | Q46617430 |
| | Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain | Q47441997 |
| | Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau. | Q47878702 |
| | A high-throughput screen for aggregation-based inhibition in a large compound library | Q48080055 |
| | Sequence of neurofibrillary changes in aging and Alzheimer's disease: A confocal study with phospho-tau antibody, AD2. | Q48492282 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3539-3547 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Structure-activity relationship of cyanine tau aggregation inhibitors | |
| P478 | volume | 52 | |